Will The FDA Follow The EMA And Order A Meridia Recall After Its September 2010 Advisory Meeting

Will The FDA Follow The EMA And Order A Meridia Recall After Its September 2010 Advisory Committee Meeting NEJM Editorial: There Should Be A Meridia Recall As The Risk Of Heart-Related Side Effects Is Greater Than Any Weight-Loss Benefit http://www.drug-injury.com/druginjurycom/2010/09/meridia-sibutramine-risk-heart-attack-mi-stroke-cvd-patients-drug-recall-fda.html
Contributor
Wilmington, North Carolina
Personal Injury
About
I have a national litigation practice based in Wilmington, North Carolina, representing people who have cases involving prescription drug injury lawsuits and asbestos-mesothelioma claims.